Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 55154-6970

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 55154-6970). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5331e8bf F327 4f66 8776 B1a111cd7da8 00

5331e8bf F327 4f66 8776 B1a111cd7da8 00
This text describes a drug called "0.25% Bupivacaine Hydrochloride Injection" that comes in 5 x 30mL single-dose tear-top vials. It is used for infiltration, nerve block, caudal, and epidural anesthesia, but not for spinal anesthesia. Each mL contains anhydrous bupivacaine hydrochloride (25mg) and sodium chloride (8.8mg). The drug is preservative-free and uses aseptic technique for administration. The package warns that it is intended for institutional use only and should be kept out of reach of children. The drug is distributed by Hospira Inc. and made in Switzerland. Storage is recommended at 20-25°C but excursions are permitted between 15-30°C.*
FDA Label Image

Hospira Logo (Bupivacaine 01)

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Bupivacaine 02)

FDA Label Image

Structural Formula Epinephrine (Bupivacaine 03)

FDA Label Image

Hpspira Logo (Bupivacaine 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.